Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2009 06:33 ET | Source: Evotec AG

Evotec to Report Third Quarter 2009 Results on 12 November 2009

HAMBURG, Germany, Nov. 6, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (Nasdaq:EVTC) will report its financial results for the third quarter of 2009 on Thursday, 12 November 2009. The...
October 22, 2009 02:05 ET | Source: Evotec AG

Evotec Receives a EUR 2.5 Million Milestone Payment in Its Research Collaboration With Boehringer Ingelheim

HAMBURG, Germany, Oct. 22, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) today announced that it has achieved another milestone in its research collaboration with Boehringer...
October 15, 2009 02:33 ET | Source: Evotec AG

Evotec Extends Medicinal Chemistry Collaboration With Ono Pharmaceutical Co., Ltd.

HAMBURG, Germany, Oct. 15, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) today announced that it has extended its current research collaboration with Ono Pharmaceutical Co., Ltd....
October 01, 2009 02:52 ET | Source: Evotec AG

Evotec Achieves Milestone With Cardioxyl Pharmaceuticals - as Compound Enters the Clinic

HAMBURG, Germany and OXFORD, United Kingdom, Oct. 1, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC), a leading provider in the discovery and development of novel small molecule...
September 09, 2009 03:00 ET | Source: Evotec AG

Evotec Announces Research Agreement With Biogen Idec

HAMBURG, Germany and OXFORD, UK, Sept. 9, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC), a leading provider in the discovery and development of novel small molecule drugs, today...
September 08, 2009 02:10 ET | Source: Evotec AG

Evotec Starts Phase I With EVT 103, An NR2B-Selective NMDA Receptor Antagonist

HAMBURG, Germany, Sept. 8, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) announced today the Phase I clinical study initiation for EVT 103, a small molecule NR2B-selective NMDA...
August 31, 2009 09:20 ET | Source: Evotec AG

Evotec Completes Acquisition of Controlling Majority Stake in Research Support International Private Limited (RSIPL)

HAMBURG, Germany, Aug. 31, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) announced today that the acquisition of the controlling majority stake of Research Support International...
August 07, 2009 01:39 ET | Source: Evotec AG

Evotec Announces Strong Second Quarter Financial Results

HAMBURG, Germany, Aug. 7, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) today reported results and corporate updates for the second quarter 2009. Recent Highlights: * Strong...
August 06, 2009 06:30 ET | Source: Evotec AG

Evotec Accelerates Growth Strategy of its Discovery Alliance Business with Acquisition of Indian RSIPL

* Evotec acquires 70% controlling majority stake of Research Support International Private Limited ('RSIPL'), India, for EUR 2.8 million in cash * Expansion of capacity accelerates...
July 30, 2009 08:19 ET | Source: Evotec AG

Evotec to Report First Half 2009 Results On August 7, 2009

HAMBURG, Germany, July 30, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) will report its financial results for the first half of 2009 on Friday, August 7, 2009. The Company is...